VIRX - Viracta Therapeutics to Present at Upcoming Investor Conferences | Benzinga
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Company's Management will participate in upcoming investor conferences in November.
Details on the conferences can be found below:
Stifel 2023 Healthcare Conference
Presentation Date: Wednesday, November 15, 2023
Presentation Time: 10:20 – 10:50 AM ET
Piper Sandler 35th Annual Healthcare Conference
Presentation Date: Tuesday, November 28, 2023